Massachusetts Controlled Substance Registrations FAQ Reference Guide To assist our customers with their Massachusetts Constrolled Substance Registrations (MCSR) compliance requirements, MedPro Systems (MedPro) is associating MA State License records to MCSR data for validation fulfillment,…
Massachusetts updates to MCSR & SLN data validation What Changed In late 2023, Massachusetts began transitioning their license data to a new platform to publish professional license (MA SLN) and all Massachusetts Controlled Substance Registration…
DOJ Introduces Safe-Harbor Policy for Disclosing Uncovered Misconduct During Mergers and Acquisitions If Your Organization May Acquire or Be Acquired by Another Corporate Entity, Be Mindful of the Critical Importance of Corporate Compliance On October…
2023 Transparency and Aggregate Spend Conference Insights The MedPro Systems team recently enjoyed attending Informa’s 2023 Transparency, Aggregate Spend & HCP Engagement conference in Washington, D.C. It was an excellent opportunity to connect with so…
Whether you are looking for guidance on the rules, benchmarking & best practices, or simply need help getting it all done, MedPro is your trusted partner…
Italy Implements New Transparency Reporting Regulations Italian Sunshine Act Overview In May 2022, Italy approved a new national transparency law regulating relations between pharmaceutical & medical device manufacturers and people operating in the healthcare sector,…
Overview Since the enactment of Open Payments (Sunshine Act), Life Sciences organizations have faced the daunting task of collecting, verifying, and reporting compliance-related spend and research. The necessary tracking is time-consuming and can be error-prone,…
Under the many challenges of COVID-19, it has been immensely more difficult for the Life Sciences industry to engage with, educate, and provide samples to healthcare providers (HCPs) regarding their products. Sales Representatives have been…
With 2019 reporting to CMS Open Payments (Sunshine Act) now complete, it’s a great time to reflect on how you can improve your current reporting processes for next year. The March 31, 2020 reports presented…
As part of the many challenges of COVID-19, sending pharmaceutical sales representatives direct to healthcare practitioners (HCPs) or healthcare organizations (HCOs) is no longer an option. The Life Sciences industry as a whole is switching…
The information being collected consists of Identifiers and Personal and Professional Information, and is being used for business and commercial purposes. Please see our Privacy Policy and Data Privacy and Security Rationale Statement for additional information.
